高级检索
当前位置: 首页 > 详情页

Clinical Efficacy Study of Pucotenlimab Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Women's hospital school of medicine zhejiang university,Hangzhou,Zhejiang,China,310000 [2]Xiangya Hospital of Central South University [3]Tongji Hospital [4]Qilu Hospital of Shandong University [5]Anhui Provincial Cancer Hospital [6]Sichuan Cancer Hospital and Research Institute [7]Henan Provincial People's Hospital [8]Hunan Cancer Hospital [9]Zhejiang Cancer Hospital [10]First Affiliated Hospital of Wenzhou Medical University [11]Ningbo No. 1 Hospital [12]The First Affiliated Hospital of Zhengzhou University

关键词: Neoadjuvant chemotherapy PD-1 inhibitor(Pucotenlimab)

研究目的:
Exploring the therapeutic effect of neoadjuvant chemotherapy combined with PD-1 inhibitors on advanced stage III-IV endometrial cancer

资源点击量:53684 今日访问量:0 总访问量:4604 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号